This informative session was designed for prospective applicants interested in the newly launched In Vivo Gene Therapy Program. The Q&A session offered practical guidance on application expectations, program alignment and opportunities to connect directly with Catalyze leadership as applicants prepare for the September 20th In Vivo Gene Therapy Expression of Interest (EOI) submission due date.
This Office Hours was hosted by the NHLBI Catalyze team on September 11th, 2026.
This video is for educational purposes only.
Download slides